Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma

Contrast Media and Molecular Imaging

Volumn 7, Issue 4, 2012, Pages 363-372

  Bu, Lihong ^a,b,c   Xie, Jin ^b   Chen, Kai ^c   Huang, Jing ^c   Aguilar, Zoraida P ^d   Wang, Andrew ^d   Sun, Kin Wai ^c   Chua, Mei Sze ^c   So, Samuel ^c   Cheng, Zhen ^b   Eden, Henry S ^a   Shen, Baozhong ^a   Chen, Xiaoyuan ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OCEAN NANOTECH LLC   (United States)

Author keywords

Hepatocarcinoma (HCC); Iron oxide nanoparticle (IONP); Liver contrast agent; Magnetic resonance imaging (MRI)

Indexed keywords

COPOLYMER; CYCLINE; NANOCOATING; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL GROWTH; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; DOSE RESPONSE; DRUG CLEARANCE; DRUG CONJUGATION; DRUG SYNTHESIS; DRUG UPTAKE; FLOW CYTOMETRY; HYDROPHOBICITY; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROLYSIS; SIGNAL NOISE RATIO; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME; ZETA POTENTIAL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DEATH; CELL LINE, TUMOR; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FERRIC COMPOUNDS; HUMANS; LIVER NEOPLASMS; LUMINESCENT MEASUREMENTS; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; PHANTOMS, IMAGING; POLYMERS; RODENTIA; SIGNAL-TO-NOISE RATIO; SOLUBILITY; STAINING AND LABELING; WATER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861665745     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.494     Document Type: Article

References (23)

1. Xie J, Huang J, Li X, Sun S, Chen X. Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem 2009; 16: 1278-1294.
2. Poeckler-Schoeniger C, Koepke J, Gueckel F, Sturm J, Georgi M. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imag 1999; 17: 383-392.
3. Ward J, Guthrie JA, Wilson D, Arnold P, Lodge JP, Toogood GJ, Wyatt JI, Robinson PJ. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging - comparison of optimized sequences. Radiology 2003; 228: 709-718.
4. Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010; 62: 1064-1079.
5. Bhirde A, Guo N, Chen X. Targeted nanoprobes reveal early time point kinetics in vivo by time-resolved MRI. Theranostics 2011;1:274-276.
6. Kessinger CW, Togao O, Khemtong C, Huang G, Takahashi M, Gao J. Investigation of in vivo targeting kinetics of alpha(v)beta(3)-specific superparamagnetic nanoprobes by time-resolved MRI. Theranostics 2011; 1: 263-273.
7. Tan M, Lu ZR. Integrin targeted MR imaging. Theranostics 2011; 1: 83-101.
8. Yallapu MM, Foy SP, Jain TK, Labhasetwar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res 2010; 27: 2283-2295.
9. Maeng JH, Lee DH, Jung KH, Bae YH, Park IS, Jeong S, Jeon YS, Shim CK, Kim W, Kim J, Lee J, Lee YM, Kim JH, Kim WH, Hong SS. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials 2010; 31: 4995-5006.
10. Das M, Dhak P, Gupta S, Mishra D, Maiti TK, Basak A, Pramanik P. Highly biocompatible and water-dispersible, amine functionalized magnetite nanoparticles, prepared by a low temperature, air-assisted polyol process: a new platform for bio-separation and diagnostics. Nanotechnology 2010; 21: 125103.
11. Xie J, Liu G, Eden HS, Ai H, Chen X. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 2011; 44: 883-892.
12. Essig M Protocol design for high relaxivity contrast agents in MR imaging of the CNS. Eur Radiol 2006; 16 Suppl 7: M3-7.
13. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011; 1810: 361-373.
14. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-2110.
15. Ho D, Sun X, Sun S. Monodisperse magnetic nanoparticles for theranostic applications. Acc Chem Res 2011; 44: 875-882.
16. Park J, Lee E, Hwang NM, Kang MS, Kim SC, Hwang Y, Park JG, Noh HJ, Kini JY, Park JH, Hyeon T. One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles. Angew Chem Int Edn 2005; 44: 2872-2877.
17. Yu WW, Falkner JC, Yavuz CT, Colvin VL. Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts. Chem Commun (Camb) 2004: 2306-2307.
18. Duan H, Kuang M, Wang X, Wang A, Mao H, Nie S. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity. J Phys Chem C 2008; 112: 8127-8131.
19. LaConte LE, Nitin N, Zurkiya O, Caruntu D, O'Connor CJ, Hu X, Bao G. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity. J Magn Reson Imag 2007; 26: 1634-1641.
20. Kaim AH, Wischer T, O'Reilly T, Jundt G, Frohlich J, von Schulthess GK, Allegrini PR. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 2002; 225: 808-814.
21. Lee HY, Lee SH, Xu C, Xie J, Lee JH, Wu B, Koh AL, Wang X, Sinclair R, Wang SX, Nishimura DG, Biswal S, Sun S, Cho SH, Chen X. Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology 2008; 19: 165101.
22. Huang J, Bu L, Xie J, Chen K, Cheng Z, Li X, Chen X. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 2010;4:7151-7160.
23. Zhu L, Xie J, Swierczewska M, Zhang F, Quan Q, Ma Y, Fang X, Kim K, Lee S, Chen X. Real-time video imaging of protease expression in vivo. Theranostics 2011; 1: 18-27.